Dr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral Laboratory

New Delhi: Diagnostic chain Dr Lal PathLabs said the board of its arm PathLabs Unifiers has approved acquisition of 70 per cent stake in Amins Pathology Referral Laboratory to strengthen its presence in Gujarat. "We are pleased to announce the acquisition of a proprietorship concern, 'Amins Pathology Referral Laboratory' by our subsidiary PathLabs Unifiers Pvt Ltd which operates diagnostics networks in Vadodara, Gujarat," Dr Lal PathLabs CEO Om Manchanda said.

Also read:- Laurus Labs to acquire subsidiary of ASPEN Pharmacare

The acquisition will further strengthen the company's network in Gujarat and adjoining areas, he added. Shares of Dr Lal PathLabs on Tuesday closed at Rs 1,367.20 per scrip on the BSE, down 1.52 per cent from its previous close.

Also read:- Roche gets USFDA clearance for cobas pro solutions for diagnostics labs